Abingdon Health Plc (AIM:ABDX)
London · Delayed Price · Currency is GBP · Price in GBX 5.77
-0.23 (-3.90%)
Feb 13, 2026, 3:56 PM GMT
Abingdon Health Market Cap
Abingdon Health has a market cap or net worth of 26 million as of February 13, 2026. Its market cap has decreased by -15.61% in one year.
Market Cap
26.00M
Enterprise Value
25.11M
Revenue
8.43M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.77
Market Cap Chart
Since December 15, 2020, Abingdon Health's market cap has decreased from 100.96M to 26.00M, a decrease of -74.24%. That is a compound annual growth rate of -23.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 26.00M | -6.25% |
| Dec 31, 2025 | 27.74M | -7.08% |
| Dec 31, 2024 | 29.85M | -10.74% |
| Dec 29, 2023 | 33.44M | 69.23% |
| Dec 30, 2022 | 19.76M | -80.30% |
| Dec 31, 2021 | 100.33M | 10.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 15, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 219.68B |
| GSK plc | 87.00B |
| Haleon | 35.66B |
| Smith & Nephew | 10.94B |
| Poolbeg Pharma | 32.43M |
| ImmuPharma | 32.38M |
| Arecor Therapeutics | 28.70M |
| Aptamer Group | 25.62M |